Citra Buana Prasida Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Citra Buana Prasida Tbk. trades at Rp510 (market cap 725.59B, 80.2K 24h volume), while Prodia Diagnostic Line Tbk trades at Rp264 (market cap 470.58B, 16.61M 24h volume). The key difference: Citra Buana Prasida Tbk. is the larger of the two by market cap, and Prodia Diagnostic Line Tbk is more actively traded (16.61M versus 80.2K). Which is the better fit depends on your goals.
| CBPE | PRDL | |
|---|---|---|
Market Cap | 725.59B | 470.58B |
Volume | 80.2K | 16.61M |
Lot | 802 | 166.07K |
Turnover | 41.14M | 4.38B |
Average Price | 512.96 | 263.54 |
Value | 41.14M | 4.38B |
Indicative Equilibrium Price | 510 | 272 |
Indicative Equilibrium Volume | 10 | 418 |
Trailing returns across standard periods
Latest headlines on both assets
PT Citra Buana Prasida Tbk Entity which was originally named PT Prasetia Sejati was established on August 24, 2000 based on the Deed of Establishment No. 18, drawn up in the presence of Ninik Sukadarwati, SH., Notary of the Bekasi Regency Level II, in Tambun. The Entity started its commercial business in 2005.
Read more on CBPE →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →